Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 16,688 | 0 | 24,258 | 19,732 | 23,868 |
| Operating Income | -16,688 | N/A | -24,258 | -19,732 | -23,868 |
| Interest Expense | 177 | 0 | 241 | 243 | 262 |
| Other Income | 7,598 | 0 | 2,409 | 2,925 | -39 |
| Pre-tax Income | -9,267 | 0 | -22,090 | -17,050 | -24,169 |
| Income Tax | 2 | N/A | 2 | N/A | N/A |
| Net Income Continuous | -9,269 | N/A | -22,092 | -17,053 | -24,169 |
| Net Income | $-9,269 | $N/A | $-22,092 | $-17,053 | $-24,169 |
| EPS Basic Total Ops | -0.10 | N/A | -0.35 | -0.30 | -0.35 |
| EPS Basic Continuous Ops | -0.11 | N/A | -0.33 | -0.25 | -0.36 |
| EPS Diluted Total Ops | -0.10 | N/A | -0.35 | -0.30 | -0.35 |
| EPS Diluted Continuous Ops | -0.11 | N/A | -0.33 | -0.25 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.30 | -0.35 | -0.30 | -0.36 |
| EBITDA(a) | $-16,688 | $N/A | $-24,258 | $-19,732 | $-23,868 |